BIOMAT Database Logo BIOMAT Database Logo

Germline p16 mutations in familial melanoma. 1994

C J Hussussian, and J P Struewing, and A M Goldstein, and P A Higgins, and D S Ally, and M D Sheahan, and W H Clark, and M A Tucker, and N C Dracopoli
Laboratory of Genetic Disease Research, National Center for Human Genome Research, National Institutes of Health, Bethesda, Maryland 20892.

The p16 gene is located in chromosome 9p21, a region that is linked to familial melanoma and homozygously deleted in many tumour cell lines. We describe eight p16 germline substitutions (one nonsense, one splice donor site and six missense) in 13/18 familial melanoma kindreds. Six of these mutations were identified in 33/36 melanoma cases in nine families, whereas two were detected in normal controls and are not disease-related. The melanoma-specific mutations were detected in 9p21-linked, but not in 1p36-linked, families, thereby confirming previous reports of genetic heterogeneity. Functional analyses of these mutations will confirm those causally related to the development of familial melanoma.

UI MeSH Term Description Entries
D008126 Lod Score The total relative probability, expressed on a logarithmic scale, that a linkage relationship exists among selected loci. Lod is an acronym for "logarithmic odds." Lod Scores,Score, Lod,Scores, Lod
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002899 Chromosomes, Human, Pair 9 A specific pair of GROUP C CHROMSOMES of the human chromosome classification. Chromosome 9
D004416 Dysplastic Nevus Syndrome Clinically atypical nevi (usually exceeding 5 mm in diameter and having variable pigmentation and ill defined borders) with an increased risk for development of non-familial cutaneous malignant melanoma. Biopsies show melanocytic dysplasia. Nevi are clinically and histologically identical to the precursor lesions for melanoma in the B-K mole syndrome. (Stedman, 25th ed) B-K Mole Syndrome,Familial Atypical Multiple Mole-Melanoma,Nevus Syndrome, Dysplastic,Nevus, Dysplastic,Dysplastic Nevi,B K Mole Syndrome,Dysplastic Nevus,Familial Atypical Multiple Mole Melanoma,Nevi, Dysplastic,Syndrome, B-K Mole,Syndrome, Dysplastic Nevus
D005260 Female Females

Related Publications

C J Hussussian, and J P Struewing, and A M Goldstein, and P A Higgins, and D S Ally, and M D Sheahan, and W H Clark, and M A Tucker, and N C Dracopoli
Germline CDKN2A/p16 mutations are rare in multiple primary and familial malignant melanoma in German patients.
February 2008, Journal of dermatological science,
C J Hussussian, and J P Struewing, and A M Goldstein, and P A Higgins, and D S Ally, and M D Sheahan, and W H Clark, and M A Tucker, and N C Dracopoli
Noncoding germline mutations in p16/CDKN2A in melanoma-prone families.
September 1999, Clinical genetics,
C J Hussussian, and J P Struewing, and A M Goldstein, and P A Higgins, and D S Ally, and M D Sheahan, and W H Clark, and M A Tucker, and N C Dracopoli
Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families.
August 2000, European journal of human genetics : EJHG,
C J Hussussian, and J P Struewing, and A M Goldstein, and P A Higgins, and D S Ally, and M D Sheahan, and W H Clark, and M A Tucker, and N C Dracopoli
Novel germline p16 mutation in familial malignant melanoma in southern Sweden.
June 1996, Cancer research,
C J Hussussian, and J P Struewing, and A M Goldstein, and P A Higgins, and D S Ally, and M D Sheahan, and W H Clark, and M A Tucker, and N C Dracopoli
Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds.
July 1995, Nature genetics,
C J Hussussian, and J P Struewing, and A M Goldstein, and P A Higgins, and D S Ally, and M D Sheahan, and W H Clark, and M A Tucker, and N C Dracopoli
Lack of germline CDK6 mutations in familial melanoma.
March 2000, Oncogene,
C J Hussussian, and J P Struewing, and A M Goldstein, and P A Higgins, and D S Ally, and M D Sheahan, and W H Clark, and M A Tucker, and N C Dracopoli
Rarity of CDK4 germline mutations in familial melanoma.
February 2002, Melanoma research,
C J Hussussian, and J P Struewing, and A M Goldstein, and P A Higgins, and D S Ally, and M D Sheahan, and W H Clark, and M A Tucker, and N C Dracopoli
AXIN2 germline mutations are rare in familial melanoma.
May 2011, Genes, chromosomes & cancer,
C J Hussussian, and J P Struewing, and A M Goldstein, and P A Higgins, and D S Ally, and M D Sheahan, and W H Clark, and M A Tucker, and N C Dracopoli
Familial uveal melanoma: absence of germline mutations involving the cyclin-dependent kinase-4 inhibitor gene (p16).
March 1996, Ophthalmic genetics,
C J Hussussian, and J P Struewing, and A M Goldstein, and P A Higgins, and D S Ally, and M D Sheahan, and W H Clark, and M A Tucker, and N C Dracopoli
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
February 1998, Human molecular genetics,
Copied contents to your clipboard!